Reducing human suffering by detecting cancer earlier with patented technology
BioCurex's RECAF(tm) marker is found in all types of major cancers
  • Demo Video
  • Private Messages
  • Edit My Profile
  • View/Edit Portfolio

Widget

Add BioCurex widget to your own site or blog

Email Updates

Search

AGORACOM News Flash

AGORACOM CONFERENCE UPDATE

  • 12 More Companies Added To Schedule For Dec 3 & 4. (See Schedule)
  • Keynote Speakers Include Peter Grandich, Eric Coffin (See Speakers)
  • Workshop Presentations Added To Thursday Schedule
  • Investors from over 45 Countries Have Visited
  • Conference Begins 2 Weeks From Today!

Looking forward to seeing all of you there gang.  Registration is free for investors.  AGORACOM Members register with just one click.  Non-members takes less than 60 seconds.  Register here (see form on right hand side)

 

Message: Biocurex Cash Position

080115_sheen
Rank: [?]
Treasurer
Points: [?]
830
Rating: [?]
Votes: 11 Score: 2.7
  • Currently 2.7/5 Stars.
Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Biocurex Cash Position

posted on Dec 09, 08 02:54PM
Has Biocurex secured enough cash to continue operating
beyond December 2008?


From the latest Form-10-Q:

"As of November 14, 2008 Biocurex has cash on hand
 of approximately $90,000. Biocurex is presently spending
 approximately $200,000 each month on research and
 development, principal and interest payments to the
Note Holders, and general and administrative expenses.

5
<PAGE>

To maintain its present level of operations, including
 research and development, and to avoid defaulting on
payments to the Note Holders, Biocurex will need to raise
 approximately $4,000,000 to satisfy its monthly cash
requirements until the notes are fully paid."


New Message

Please login to post a reply

AGORACOM Quick Tips

Bullish On China? AGORACOM Launches ChinaSecurities.com ... Check It Out

Executive Address

Bocx-ricardo-ea
Dr. Ricardo Moro
President & CEO
November 27, 2008

Dr. Moro discusses Biocurex's latest developments

View Broadcast

Stock Quote